Search for a doctor

Paul E. Croarkin, D.O., M.S.

  1. Psychiatrist
Request an Appointment

Publications

  1. Wischnewski M, Shirinpour S, Alekseichuk I, Lapid MI, Nahas Z, Lim KO, Croarkin PE, Opitz A. Real-time TMS-EEG for brain state-controlled research and precision treatment: a narrative review and guide. J Neural Eng. 2024 Nov 1; 21 (6) Epub 2024 Nov 01
    View PubMed
  2. Marrero-Polanco J, Joyce JB, Grant CW, Croarkin PE, Athreya AP, Bobo WV. Predicting remission after acute phase pharmacotherapy in patients with bipolar I depression: A machine learning approach with cross-trial and cross-drug replication. Bipolar Disord. 2024 Oct 3 Epub 2024 Oct 03
    View PubMed
  3. Grant CW, Marrero-Polanco J, Joyce JB, Barry B, Stillwell A, Kruger K, Anderson T, Talley H, Hedges M, Valery J, White R, Sharp RR, Croarkin PE, Dyrbye LN, Bobo WV, Athreya AP. Pharmacogenomic augmented machine learning in electronic health record alerts: A health system-wide usability survey of clinicians. Clin Transl Sci. 2024 Oct; 17 (10):e70044
    View PubMed
  4. Lewis CP, Nakonezny PA, Sonmez AI, Ozger C, Garzon JF, Camsari DD, Yuruk D, Romanowicz M, Shekunov J, Zaccariello MJ, Vande Voort JL, Croarkin PE. A Dose-Finding, Biomarker Validation, and Effectiveness Study of Transcranial Magnetic Stimulation for Adolescents With Depression. J Am Acad Child Adolesc Psychiatry. 2024 Sep 6 Epub 2024 Sept 06
    View PubMed
  5. Ho MF, Zhang C, Cohan JS, Tuncturk M, Heider RM, Coombes BJ, Biernacka J, Moon I, Skime M, Ho AM, Ngo Q, Skillon C, Croarkin PE, Oesterle TS, Karpyak VM, Li H, Weinshilboum RM. IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study. Brain Behav Immun. 2024 Aug; 120:304-314 Epub 2024 June 08
    View PubMed
  6. Barac M, Scaletty S, Hassett LC, Stillwell A, Croarkin PE, Chauhan M, Chesak S, Bobo WV, Athreya AP, Dyrbye LN. Wearable Technologies for Detecting Burnout and Well-Being in Health Care Professionals: Scoping Review. J Med Internet Res. 2024 Jun 25; 26:e50253.
    View PubMed
  7. Thai M, Nair AU, Klimes-Dougan B, Albott CS, Silamongkol T, Corkrum M, Hill D, Roemer JW, Lewis CP, Croarkin PE, Lim KO, Widge AS, Nahas Z, Eberly LE, Cullen KR. Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness. J Affect Disord. 2024 Jun 1; 354:589-600 Epub 2024 Mar 12
    View PubMed
  8. Elmaghraby R, Pines A, Geske JR, Coombes BJ, Leung JG, Croarkin PE, Markota M, Bobo WV. Risk of Newly Diagnosed Psychotic Symptoms in Youth Receiving Medications for Attention-Deficit/Hyperactivity Disorder. JAACAP Open. 2024 Jun; 2 (2):135-144 Epub 2024 Feb 05
    View PubMed
  9. Aaronson ST, Goldwaser EL, Croarkin PE, Geske JR, LeMahieu A, Sklar JH, Kung S. A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression. J Clin Psychiatry. 2024 May 20; 85 (2)
    View PubMed
  10. Bormann NL, Oesterle TS, Arndt S, Karpyak VM, Croarkin PE. Systematic review and meta-analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders. Am J Addict. 2024 May; 33 (3):269-282 Epub 2024 Jan 25
    View PubMed
  11. Naik A, Bah M, Govande M, Palsgaard P, Dharnipragada R, Shaffer A, Air EL, Cramer SW, Croarkin PE, Arnold PM. Optimal Frequency in Repetitive Transcranial Magnetic Stimulation for the Management of Chronic Pain: A Network Meta-Analysis of Randomized Controlled Trials. World Neurosurg. 2024 Apr; 184:e53-e64 Epub 2024 Jan 06
    View PubMed
  12. Balzekas I, Trzasko J, Yu G, Richner TJ, Mivalt F, Sladky V, Gregg NM, Van Gompel J, Miller K, Croarkin PE, Kremen V, Worrell GA. Method for cycle detection in sparse, irregularly sampled, long-term neuro-behavioral timeseries: Basis pursuit denoising with polynomial detrending of long-term, inter-ictal epileptiform activity. PLoS Comput Biol. 2024 Apr; 20 (4):e1011152 Epub 2024 Apr 25
    View PubMed
  13. Naik A, Bah M, Govande M, Palsgaard P, Dharnipragada R, Shaffer A, Air EL, Cramer SW, Croarkin PE, Arnold PM. Optimal frequency in repetitive transcranial magnetic stimulation for the management of chronic pain: a network meta-analysis of randomized controlled trials. World Neurosurgery. 2024 Apr; 184:e53-64
  14. Yuruk D, Ozger C, Garzon JF, Nakonezny PA, Vande Voort JL, Croarkin PE. A retrospective, naturalistic study of deep brain stimulation and vagal nerve stimulation in young patients. Brain Behav. 2024 Mar; 14 (3):e3452
    View PubMed
  15. Croarkin PE. Understanding the Developmental Lines of Psychosis Spectrum Symptoms: Efforts and Early Insights From the Toronto Adolescent and Youth Cohort Study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Mar; 9 (3):247-248
    View PubMed
  16. Croarkin PE, Opitz A. Advances in precision neuromodulation: electroconvulsive therapy amplitude titration. Neuropsychopharmacology. 2024 Mar; 49 (4):635-636 Epub 2024 Jan 09
    View PubMed
  17. Wilton AR, Sheffield K, Wilkes Q, Chesak S, Pacyna J, Sharp R, Croarkin PE, Chauhan M, Dyrbye LN, Bobo WV, Athreya AP. The Burnout PRedictiOn Using Wearable aNd ArtIficial IntelligEnce (BROWNIE) study: a decentralized digital health protocol to predict burnout in registered nurses. BMC Nurs. 2024 Feb 13; 23(1):114.
    View PubMed
  18. Pagali SR, Kumar R, LeMahieu AM, Basso MR, Boeve BF, Croarkin PE, Geske JR, Hassett LC, Huston J 3rd, Kung S, Lundstrom BN, Petersen RC, St Louis EK, Welker KM, Worrell GA, Pascual-Leone A, Lapid MI. Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer's disease, Alzheimer's disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis. Int Psychogeriatr. 2024 Feb 8; 1-49 Epub 2024 Feb 08
    View PubMed
  19. Nooraeen S, Croarkin PE, Geske JR, Shekunov J, Orth SS, Romanowicz M, Frye MA, Vande Voort JL. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing. J Child Adolesc Psychopharmacol. 2024 Feb; 34 (1):28-33
    View PubMed
  20. Lynch BA, Lewis CP, Vande Voort JL, Nandakumar AL, Brennan RM, Cole KC, Rackley SJ, Wi CI, Croarkin PE, Romanowicz M. Impact of Family Structure on Adolescent Depression Outcomes in a Collaborative Care Program. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241291790
    View PubMed
  21. Wheeler L, Worrell SE, Balzekas I, Bilderbeek J, Hermes D, Croarkin P, Messina S, Van Gompel J, Miller KJ, Kremen V, Worrell GA. Case report: Bridging limbic network epilepsy with psychiatric, memory, and sleep comorbidities: case illustrations of reversible psychosis symptoms during continuous, high-frequency ANT-DBS. Front Netw Physiol. 2024; 4:1426743 Epub 2024 Aug 08
    View PubMed
  22. Smith JR, DiSalvo M, Green A, Ceranoglu TA, Anteraper SA, Croarkin P, Joshi G. Treatment Response of Transcranial Magnetic Stimulation in Intellectually Capable Youth and Young Adults with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Neuropsychol Rev. 2023 Dec; 33 (4):834-855 Epub 2022 Sept 26
    View PubMed
  23. Dhami P, Moreno S, Croarkin PE, Blumberger DM, Daskalakis ZJ, Farzan F. Baseline markers of cortical excitation and inhibition predict response to theta burst stimulation treatment for youth depression. Sci Rep. 2023 Nov 4; 13 (1):19115 Epub 2023 Nov 04
    View PubMed
  24. Romanowicz M, Croarkin KS, Elmaghraby R, Skime M, Croarkin PE, Vande Voort JL, Shekunov J, Athreya AP. Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study. J Child Adolesc Psychopharmacol. 2023 Nov; 33 (9):387-392
    View PubMed
  25. Ho MF, Zhang C, Moon I, Biernacka J, Coombes B, Ngo Q, Skillon C, Skime M, Oesterle T, Croarkin PE, Karpyak VM, Li H, Weinshilboum RM. Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation. Mol Metab. 2023 Nov; 77:101798 Epub 2023 Sept 07
    View PubMed
  26. Betcher HK, Bommersbach TJ, Perossa BA, Larrabee B, Croarkin PE, Romanowicz M, Vande Voort JL, McKean AJ. Adult Outcomes of Children With Reactive Attachment Disorder in a Non-Institutionalized Sample. J Clin Psychiatry. 2023 Oct 18; 84 (6)
    View PubMed
  27. Sim LA, Vickers KS, Croarkin PE, Williams MD, Clark MM, Derscheid DJ, Lapid MI. The Relationship of Mentorship to Career Outcomes in Academic Psychiatry and Psychology: a Needs Assessment. Acad Psychiatry. 2023 Oct; 47 (5):521-525 Epub 2022 Dec 29
    View PubMed
  28. Mivalt F, Kremen V, Sladky V, Cui J, Gregg NM, Balzekas I, Marks V, St Louis EK, Croarkin P, Lundstrom BN, Nelson N, Kim J, Hermes D, Messina S, Worrell S, Richner T, Brinkmann BH, Denison T, Miller KJ, Van Gompel J, Stead M, Worrell GA. Impedance Rhythms in Human Limbic System. J Neurosci. 2023 Sep 27; 43 (39):6653-6666 Epub 2023 Aug 24
    View PubMed
  29. Ozger C, Chumachenko S, McVoy M, Croarkin PE, Doruk Camsari D. Evidence for Altered Electroencephalography Coherence in Depressed Adolescents with Suicidal Ideation and Behaviors. J Child Adolesc Psychopharmacol. 2023 Sep; 33 (7):287-293 Epub 2023 Sept 05
    View PubMed
  30. Doruk Camsari D, Lewis CP, Sonmez AI, Ozger C, Fatih P, Yuruk D, Shekunov J, Vande Voort JL, Croarkin PE. Event-Related Potential Markers of Suicidality in Adolescents. Int J Neuropsychopharmacol. 2023 Aug 29; 26 (8):566-575
    View PubMed
  31. Deng ZD, Robins PL, Dannhauer M, Haugen LM, Port JD, Croarkin PE. Optimizing TMS Coil Placement Approaches for Targeting the Dorsolateral Prefrontal Cortex in Depressed Adolescents: An Electric Field Modeling Study. Biomedicines. 2023 Aug 21; 11 (8)
    View PubMed
  32. Holland AL, Sharma P, Kurani S, Pazdernik V, Patten C, Kremers HM, Croarkin P, Kamath C, Glasgow A, Sangaralingham L, Geske J, Prasad K, St Sauver J. Longitudinal factors associated with increased alcohol consumption in adults during the COVID-19 pandemic. Am J Drug Alcohol Abuse. 2023 Jul 4; 49 (4):481-490 Epub 2023 Mar 07
    View PubMed
  33. Chochol MD, Gandhi K, Croarkin PE. Social Media and Anxiety in Youth: A Narrative Review and Clinical Update. Child Adolesc Psychiatr Clin N Am. 2023 Jul; 32 (3):613-630 Epub 2023 Mar 28
    View PubMed
  34. Kumar R, LeMahieu AM, Stan MN, Seshadri A, Ozerdem A, Pazdernik VK, Haynes TL, Daugherty DH 3rd, Sundaresh V, Veldic M, Croarkin PE, Frye MA, Singh B. The Association Between Thyroid Stimulating Hormone and Depression: A Historical Cohort Study. Mayo Clin Proc. 2023 Jul; 98 (7):1009-1020
    View PubMed
  35. Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy. 2023 Jul; 43 (7):675-690 Epub 2023 Jan 27
    View PubMed
  36. Sharma P, Nguyen QA, Kurani S, Holland A, Maradit Kremers H, Pazdernik V, St Sauver J, Croarkin P, Kamath C, Geske J, Prasad K, Glasgow A, Sangaralingham L, Patten C. Association of socio-demographic characteristics with alcohol use initiation among never users during the COVID-19 pandemic: a longitudinal study. J Public Health (Oxf). 2023 Jun 14; 45 (2):442-449
    View PubMed
  37. Ayvaci ER, Croarkin PE. Special Populations: Treatment-Resistant Depression in Children and Adolescents. Psychiatr Clin North Am. 2023 Jun; 46 (2):359-370 Epub 2023 Mar 15
    View PubMed
  38. Christensen JA, Oh J, Linder K, Imhof RL, Croarkin PE, Bostwick JM, McKean AJS. Systematic Review of Interventions to Reduce Suicide Risk in Transgender and Gender Diverse Youth. Child Psychiatry Hum Dev. 2023 May 10 [Epub ahead of print]
    View PubMed
  39. Alawi M, Lee PF, Deng ZD, Goh YK, Croarkin PE. Modelling the differential effects of age on transcranial magnetic stimulation induced electric fields. J Neural Eng. 2023 Mar 16; 20 (2)
    View PubMed
  40. Strawn JR, Mills JA, Suresh V, Mayes T, Gentry MT, Trivedi M, Croarkin PE. The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder. J Psychiatr Res. 2023 Mar; 159:266-273 Epub 2023 Jan 28
    View PubMed
  41. Mohamed AK, Croarkin PE, Jha MK, Vande Voort JL. Early reduction in irritability is associated with improved outcomes among youth with depression: Findings from the AMOD study. J Affect Disord. 2023 Mar 1; 324:77-81 Epub 2022 Dec 19
    View PubMed
  42. Kumar R, Garzon J, Yuruk D, Hassett LC, Saliba M, Ozger C, Oztosun C, Ahern K, Athreya AP, Singh B, Croarkin PE, Vande Voort JL. Efficacy and safety of lamotrigine in pediatric mood disorders: A systematic review. Acta Psychiatr Scand. 2023 Mar; 147 (3):248-256 Epub 2022 Sept 21
    View PubMed
  43. Na PJ, Yaramala SR, Kim JA, Kim H, Goes FS, Zandi PP, Vande Voort JL, Sutor B, Croarkin PE, Bobo WV. Corrigendum to "The PHQ-9 item 9 based screening for suicide risk: A validation study of the patient health questionnaire (PHQ)-9 item 9 with the Columbia suicide severity rating scale (C-SSRS)" [J. Affect. Disord. 232 (2018) 34-40]. J Affect Disord. 2023 Feb 15; 323:900 Epub 2022 Dec 08
    View PubMed
  44. Saliba M, Drapeau N, Skime M, Hu X, Accardi CJ, Athreya AP, Kolacz J, Shekunov J, Jones DP, Croarkin PE, Romanowicz M. PISTACHIo (PreemptIon of diSrupTive behAvior in CHIldren): real-time monitoring of sleep and behavior of children 3-7 years old receiving parent-child interaction therapy augment with artificial intelligence - the study protocol, pilot study. Pilot Feasibility Stud. 2023 Feb 9; 9 (1):23 Epub 2023 Feb 09
    View PubMed
  45. Ahern KB, Garzon JF, Yuruk D, Saliba M, Ozger C, Vande Voort JL, Croarkin PE. Long-Interval Intracortical Inhibition and the Cortical Silent Period in Youth. Biomedicines. 2023 Jan 30; 11 (2)
    View PubMed
  46. Nooraeen S, Croarkin PE. Protest suicide: considerations for psychiatrists and psychologists. Front Psychiatry. 2023; 14:1213420 Epub 2023 June 15
    View PubMed
  47. Yuruk D, Ozger C, Garzon JF, Leffler JM, Shekunov J, Vande Voort JL, Zaccariello MJ, Nakonezny PA, Croarkin PE. Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial. PLoS One. 2023; 18 (4):e0280010 Epub 2023 Apr 13
    View PubMed
  48. Kumar R, Joseph B, Pazdernik VM, Geske J, Nuñez NA, Pahwa M, Kashani KB, Veldic M, Betcher HK, Moore KM, Croarkin PE, Ozerdem A, Cuellar-Barboza AB, McElroy SL, Biernacka JM, Frye MA, Singh B. Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy. J Clin Psychopharmacol. 2023 Jan-Feb 01; 43(1):6-11.
    View PubMed
  49. Sharma P, Kamath C, Kurani S, Pazdernik V, Kremers HM, St Sauver J, Croarkin P, Geske J, Prasad K, Patten C, Holland A. Longitudinal Correlates of Increased Alcohol Use Among Adolescents and Young Adults During the COVID-19 Pandemic. Alcohol Alcohol. 2022 Nov 11; 57 (6):648-655
    View PubMed
  50. Athreya AP, Vande Voort JL, Shekunov J, Rackley SJ, Leffler JM, McKean AJ, Romanowicz M, Kennard BD, Emslie GJ, Mayes T, Trivedi M, Wang L, Weinshilboum RM, Bobo WV, Croarkin PE. Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants. J Child Psychol Psychiatry. 2022 Nov; 63 (11):1347-1358 Epub 2022 Mar 15
    View PubMed
  51. Burke TA, Domoff SE, Croarkin PE, Romanowicz M, Borgen A, Wolff J, Nesi J. Reactions to naturalistic smartphone deprivation among psychiatrically hospitalized adolescents. J Psychiatr Res. 2022 Nov; 155:17-23 Epub 2022 Aug 01
    View PubMed
  52. Sigrist C, Vockel J, MacMaster FP, Farzan F, Croarkin PE, Galletly C, Kaess M, Bender S, Koenig J. Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. Eur Child Adolesc Psychiatry. 2022 Oct; 31 (10):1501-1525 Epub 2022 June 24
    View PubMed
  53. Mills JA, Suresh V, Chang L, Mayes T, Croarkin PE, Trivedi MH, Strawn JR. Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder. Psychiatr Serv. 2022 Sep 1; 73 (9):965-969 Epub 2022 Mar 31
    View PubMed
  54. Hennessy LA, Seewoo BJ, Jaeschke LA, Mackie LA, Figliomeni A, Arena-Foster Y, Etherington SJ, Dunlop SA, Croarkin PE, Rodger J. Accelerated low-intensity rTMS does not rescue anxiety behaviour or abnormal connectivity in young adult rats following chronic restraint stress. Neuroimage Rep. 2022 Sep; 2 (3) Epub 2022 May 26
    View PubMed
  55. Seewoo BJ, Rodger J, Demitrack MA, Heart KL, Port JD, Strawn JR, Croarkin PE. Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation. Int J Neuropsychopharmacol. 2022 Aug 16; 25 (8):619-630
    View PubMed
  56. Zhang C, Virani S, Mayes T, Carmody T, Croarkin PE, Weinshilboum R, Rush AJ, Trivedi M, Athreya AP, Bobo WV. Toward a Definition of "No Meaningful Benefit" From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales. J Clin Psychiatry. 2022 Jun 27; 83 (4) Epub 2022 June 27
    View PubMed
  57. Moxon-Emre I, Croarkin PE, Daskalakis ZJ, Blumberger DM, Lyon RE, Tani H, Truong P, Lai MC, Desarkar P, Sailasuta N, Szatmari P, Ameis SH. NAA/Glu Ratio Associated with Suicidal Ideation in Pilot Sample of Autistic Youth and Young Adults. Brain Sci. 2022 Jun 15; 12 (6) Epub 2022 June 15
    View PubMed
  58. Kucuker MU, Ozerdem A, Ceylan D, Cabello-Arreola A, Ho AMC, Joseph B, Webb LM, Croarkin PE, Frye MA, Veldic M. The role of base excision repair in major depressive disorder and bipolar disorder. J Affect Disord. 2022 Jun 1; 306:288-300 Epub 2022 Mar 16
    View PubMed
  59. Zhang CY, Voort JLV, Yuruk D, Mills JA, Emslie GJ, Kennard BD, Mayes T, Trivedi M, Bobo WV, Strawn JR, Athreya AP, Croarkin PE. A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales. J Child Adolesc Psychopharmacol. 2022 Jun; 32 (5):278-287
    View PubMed
  60. Elmaghraby R, Sun Q, Ozger C, Shekunov J, Romanowicz M, Croarkin PE. A Systematic Review of the Safety and Tolerability of Theta Burst Stimulation in Children and Adolescents. Neuromodulation. 2022 Jun; 25 (4):494-503 Epub 2022 Feb 02
    View PubMed
  61. Collins AR, Cheung J, Croarkin PE, Kolla BP, Kung S. Effects of transcranial magnetic stimulation on sleep quality and mood in patients with major depressive disorder. J Clin Sleep Med. 2022 May 1; 18 (5):1297-1305
    View PubMed
  62. Seewoo BJ, Hennessy LA, Jaeschke LA, Mackie LA, Etherington SJ, Dunlop SA, Croarkin PE, Rodger J. A Preclinical Study of Standard Versus Accelerated Transcranial Magnetic Stimulation for Depression in Adolescents. J Child Adolesc Psychopharmacol. 2022 Apr; 32 (3):187-193 Epub 2021 Dec 31
    View PubMed
  63. Welch V, Wy TJ, Ligezka A, Hassett LC, Croarkin PE, Athreya AP, Romanowicz M. Use of Mobile and Wearable Artificial Intelligence in Child and Adolescent Psychiatry: Scoping Review. J Med Internet Res. 2022 Mar 14; 24 (3):e33560
    View PubMed
  64. Hu Y, Nassan M, Singh B, Croarkin PE, Kung S. Response rate underreports improvement in patients with major depressive disorder and comorbidities treated with repetitive transcranial magnetic stimulation (rTMS) Psychiatry Research Communications. 03/08/2022; 2(2).
  65. Grant CW, Barreto EF, Kumar R, Kaddurah-Daouk R, Skime M, Mayes T, Carmody T, Biernacka J, Wang L, Weinshilboum R, Trivedi MH, Bobo WV, Croarkin PE, Athreya AP. Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder. J Pers Med. 2022 Mar 6; 12 (3) Epub 2022 Mar 06
    View PubMed
  66. Parikh TK, Strawn JR, Walkup JT, Croarkin PE. Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis. Int J Neuropsychopharmacol. 2022 Feb 11; 25 (2):144-146
    View PubMed
  67. Strawn JR, Mills JA, Suresh V, Peris TS, Walkup JT, Croarkin PE. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety. J Affect Disord. 2022 Feb 1; 298 (Pt A):292-300 Epub 2021 Oct 31
    View PubMed
  68. Romanowicz M, Oesterle TS, Croarkin PE, Sutor B. Measuring patient satisfaction in an outpatient psychiatric clinic. What factors play a role? Ann Gen Psychiatry. 2022 Jan 18; 21 (1):2
    View PubMed
  69. Markota M, Croarkin PE, Bobo WV. Positive Urine Drug Screens and External Mortality in Teenagers Who Present for Medical Care. J Clin Psychiatry. 2022 Jan 11; 83 (1)
    View PubMed
  70. Wilson S, Croarkin PE, Aaronson ST, Carpenter LL, Cochran M, Stultz DJ, Kozel FA. Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS. J Affect Disord. 2022 Jan 1; 296:79-88 Epub 2021 Sept 17
    View PubMed
  71. Vande Voort JL, Orth SS, Shekunov J, Romanowicz M, Geske JR, Ward JA, Leibman NI, Frye MA, Croarkin PE. A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression. J Am Acad Child Adolesc Psychiatry. 2022 Jan; 61 (1):46-55 Epub 2021 June 05
    View PubMed
  72. Dhami P, Lee J, Schwartzmann B, Knyahnytska Y, Atluri S, Christie GJ, Croarkin PE, Blumberger DM, Daskalakis ZJ, Moreno S, Farzan F. Neurophysiological impact of theta burst stimulation followed by cognitive exercise in treatment of youth depression. Journal of Affective Disorders Reports. 2022; 10:100439
  73. Nunez NA, Coombes BJ, Romo-Nava F, Bond DJ, Vande Voort J, Croarkin PE, Leibman N, Gardea Resendez M, Veldic M, Betcher H, Singh B, Colby C, Cuellar-Barboza A, Prieto M, Moore KM, Ozerdem A, McElroy SL, Frye MA, Biernacka JM. Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder. Front Psychiatry. 2022; 13:884217 Epub 2022 Apr 14
    View PubMed
  74. Grant CW, Wilton AR, Kaddurah-Daouk R, Skime M, Biernacka J, Mayes T, Carmody T, Wang L, Lazaridis K, Weinshilboum R, Bobo WV, Trivedi MH, Croarkin PE, Athreya AP. Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder. Front Pharmacol. 2022; 13:984383 Epub 2022 Oct 03
    View PubMed
  75. Ho MF, Zhang C, Moon I, Coombes BJ, Biernacka J, Skime M, Choi DS, Croarkin PE, Frye MA, Ngo Q, Skillon C, Oesterle TS, Karpyak VM, Li H, Weinshilboum RM. Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder. Front Pharmacol. 2022; 13:986238 Epub 2022 Sept 01
    View PubMed
  76. Kahl CK, Swansburg R, Kirton A, Pringsheim T, Wilcox G, Zewdie E, Harris A, Croarkin PE, Nettel-Aguirre A, Chenji S, MacMaster FP. Targeted Interventions in Tourette's using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette's syndrome. BMJ Open. 2021 Dec 24; 11 (12):e053156
    View PubMed
  77. Wang C, Hu Y, Nakonezny PA, Melo V, Ale C, Athreya AP, Shekunov J, Lynch R, Croarkin PE, Romanowicz M. A Retrospective Examination of the Impact of Pharmacotherapy on Parent-Child Interaction Therapy. J Child Adolesc Psychopharmacol. 2021 Dec; 31 (10):685-691 Epub 2021 July 28
    View PubMed
  78. Kalman JL, Olde Loohuis LM, Vreeker A, McQuillin A, Stahl EA, Ruderfer D, Grigoroiu-Serbanescu M, Panagiotaropoulou G, Ripke S, Bigdeli TB, Stein F, Meller T, Meinert S, Pelin H, Streit F, Papiol S, Adams MJ, Adolfsson R, Adorjan K, Agartz I, Aminoff SR, Anderson-Schmidt H, Andreassen OA, Ardau R, Aubry JM, Balaban C, Bass N, Baune BT, Bellivier F, Benabarre A, Bengesser S, Berrettini WH, Boks MP, Bromet EJ, Brosch K, Budde M, Byerley W, Cervantes P, Chillotti C, Cichon S, Clark SR, Comes AL, Corvin A, Coryell W, Craddock N, Craig DW, Croarkin PE, Cruceanu C, Czerski PM, Dalkner N, Dannlowski U, Degenhardt F, Del Zompo M, DePaulo JR, Djurovic S, Edenberg HJ, Eissa MA, Elvsashagen T, Etain B, Fanous AH, Fellendorf F, Fiorentino A, Forstner AJ, Frye MA, Fullerton JM, Gade K, Garnham J, Gershon E, Gill M, Goes FS, Gordon-Smith K, Grof P, Guzman-Parra J, Hahn T, Hasler R, Heilbronner M, Heilbronner U, Jamain S, Jimenez E, Jones I, Jones L, Jonsson L, Kahn RS, Kelsoe JR, Kennedy JL, Kircher T, Kirov G, Kittel-Schneider S, Klohn-Saghatolislam F, Knowles JA, Kranz TM, Lagerberg TV, Landen M, Lawson WB, Leboyer M, Li QS, Maj M, Malaspina D, Manchia M, Mayoral F, McElroy SL, McInnis MG, McIntosh AM, Medeiros H, Melle I, Milanova V, Mitchell PB, Monteleone P, Monteleone AM, Nothen MM, Novak T, Nurnberger JI, O'Brien N, O'Connell KS, O'Donovan C, O'Donovan MC, Opel N, Ortiz A, Owen MJ, Palsson E, Pato C, Pato MT, Pawlak J, Pfarr JK, Pisanu C, Potash JB, Rapaport MH, Reich-Erkelenz D, Reif A, Reininghaus E, Repple J, Richard-Lepouriel H, Rietschel M, Ringwald K, Roberts G, Rouleau G, Schaupp S, Scheftner WA, Schmitt S, Schofield PR, Schubert KO, Schulte EC, Schweizer B, Senner F, Severino G, Sharp S, Slaney C, Smeland OB, Sobell JL, Squassina A, Stopkova P, Strauss J, Tortorella A, Turecki G, Twarowska-Hauser J, Veldic M, Vieta E, Vincent JB, Xu W, Zai CC, Zandi PP, Di Florio A, Smoller JW, Biernacka JM, McMahon FJ, Alda M, Muller-Myhsok B, Koutsouleris N, Falkai P, Freimer NB, Andlauer TFM, Schulze TG, Ophoff RA, Psychiatric Genomics Consortium (PGC) Bipolar Disorder Working Group//International Consortium on Lithium Genetics (ConLiGen)//Colombia-US Cross Disorder Collaboration in Psychiatric Genetics. Characterisation of age and polarity at onset in bipolar disorder. Br J Psychiatry. 2021 Dec; 219 (6):659-669
    View PubMed
  79. Gandhi KD, Romanowicz M, Croarkin PE, Thapa P, Limbeck M, Desai J, Benarroch AJM, Shekunov J. Childhood psychiatric outcomes in the context of suspected neglect and abuse reports related and unrelated to parental substance use. Child Abuse Negl. 2021 Dec; 122:105344 Epub 2021 Sept 29
    View PubMed
  80. Sonmez AI, Lewis CP, Port JD, Athreya AP, Choi DS, Zaccariello MJ, Shekunov J, Blacker CJ, Croarkin PE. A pilot spectroscopy study of adversity in adolescents. Biomark Neuropsychiatry. 2021 Dec; 5 Epub 2021 Oct 02
    View PubMed
  81. Markota M, Coombes BJ, Bieber ED, Kirchoff RW, Bobo WV, Croarkin PE. Relative Age Effect on Problematic Alcohol Use in Adolescents. J Child Adolesc Psychopharmacol. 2021 Dec; 31 (10):692-696 Epub 2021 July 27
    View PubMed
  82. Melo V, Zaccariello M, Girard E, Croarkin P, Romanowicz M. Internet parent-child interaction therapy (I-PCIT) in medically ill child: A case report. Medicine (Baltimore). 2021 Oct 15; 100 (41):e27547
    View PubMed
  83. Nunez NA, Sola C, Kung S, Singh B, Ozerdem A, Veldic M, Croarkin PE, Moore KM, Betcher HK, Vande JL, Geske JR, Biernacka JM, Rummans TA, Bahn RS, Frye MA. Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders Personalized Medicine in Psychiatry. 2021; 29-30.
  84. Joyce JB, Grant CW, Liu D, MahmoudianDehkordi S, Kaddurah-Daouk R, Skime M, Biernacka J, Frye MA, Mayes T, Carmody T, Croarkin PE, Wang L, Weinshilboum R, Bobo WV, Trivedi MH, Athreya AP. Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication. Transl Psychiatry. 2021 Oct 7; 11 (1):513 Epub 2021 Oct 07
    View PubMed
  85. Shafi RMA, Nakonezny PA, Miller KA, Desai J, Almorsy AG, Ligezka AN, Morath BA, Romanowicz M, Croarkin PE. An exploratory study of clinical and physiological correlates of problematic social media use in adolescents. Psychiatry Res. 2021 Aug; 302:114020 Epub 2021 May 19
    View PubMed
  86. Kahl CK, Kirton A, Pringsheim T, Croarkin PE, Zewdie E, Swansburg R, Wrightson J, Langevin LM, Macmaster FP. Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome. Dev Med Child Neurol. 2021 Jul; 63 (7):808-815 Epub 2021 Feb 25
    View PubMed
  87. Gandhi KD, Schak KM, Vande JL, Shekunov J, Lynch BA, Rummans TA, Geske JR, Pease ER, Limbeck MG, Desai J, Croarkin PE, Romanowicz M. The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes. Prim Care Companion CNS Disord. 2021 Jun 10; 23 (3) Epub 2021 June 10
    View PubMed
  88. Ligezka AN, Sonmez AI, Corral-Frias MP, Golebiowski R, Lynch B, Croarkin PE, Romanowicz M. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8; 108:110187 Epub 2020 Dec 01
    View PubMed
  89. Shafi RMA, Nakonezny PA, Romanowicz M, Nandakumar AL, Suarez L, Croarkin PE. Suicidality and self-injurious behavior among adolescent social media users at psychiatric hospitalization. CNS Spectr. 2021 Jun; 26 (3):275-281 Epub 2020 Apr 27
    View PubMed
  90. Athreya AP, Bruckl T, Binder EB, John Rush A, Biernacka J, Frye MA, Neavin D, Skime M, Monrad D, Iyer RK, Mayes T, Trivedi M, Carter RE, Wang L, Weinshilboum RM, Croarkin PE, Bobo WV. Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings. Neuropsychopharmacology. 2021 Jun; 46 (7):1272-1282 Epub 2021 Jan 15
    View PubMed
  91. Elmaghraby R, Sun Q, Ozger C, Shekunov J, Romanowicz M, Croarkin PE. A Systematic Review of the Safety and Tolerability of Theta Burst Stimulation in Children and Adolescents. Neuromodulation. 2021 May 26 [Epub ahead of print]
    View PubMed
  92. Wong MY, Croarkin PE, Lee CK, Lee PF. Validation of Pictorial Mood Assessment with Ottawa Mood Scales and the Positive and Negative Affect Scale for Young Adults. Community Ment Health J. 2021 Apr; 57 (3):529-539 Epub 2020 July 13
    View PubMed
  93. Shafi RMA, Nakonezny PA, Miller KA, Desai J, Almorsy AG, Ligezka AN, Morath BA, Romanowicz M, Croarkin PE. Altered markers of stress in depressed adolescents after acute social media use. J Psychiatr Res. 2021 Apr; 136:149-156 Epub 2021 Feb 02
    View PubMed
  94. Goel C, Shafi RMA, Conner AJ, Waters F, Croarkin PE, McGorry P. A Retrospective Evaluation of a Pilot Youth Community Assessment and Treatment Service. Psychiatr Serv. 2021 Apr 1; 72 (4):415-420 Epub 2021 Feb 09
    View PubMed
  95. Dobson ET, Croarkin PE, Schroeder HK, Varney ST, Mossman SA, Cecil K, Strawn JR. Bridging Anxiety and Depression: A Network Approach in Anxious Adolescents. J Affect Disord. 2021 Feb 1; 280 (Pt A):305-314 Epub 2020 Nov 11
    View PubMed
  96. Dhami P, Atluri S, Lee J, Knyahnytska Y, Croarkin PE, Blumberger DM, Daskalakis ZJ, Farzan F. Neurophysiological markers of response to theta burst stimulation in youth depression. Depress Anxiety. 2021 Feb; 38 (2):172-184 Epub 2020 Oct 01
    View PubMed
  97. Croarkin PE, Elmaadawi AZ, Aaronson ST, Schrodt GR Jr, Holbert RC, Verdoliva S, Heart KL, Demitrack MA, Strawn JR. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial. Neuropsychopharmacology. 2021 Jan; 46 (2):462-469 Epub 2020 Sept 12
    View PubMed
  98. Moxon-Emre I, Daskalakis ZJ, Blumberger DM, Croarkin PE, Lyon RE, Forde NJ, Tani H, Truong P, Lai MC, Desarkar P, Sailasuta N, Szatmari P, Ameis SH. Modulation of Dorsolateral Prefrontal Cortex Glutamate/Glutamine Levels Following Repetitive Transcranial Magnetic Stimulation in Young Adults With Autism. Front Neurosci. 2021; 15:711542 Epub 2021 Oct 06
    View PubMed
  99. Alawi M, Foong LP, Kheng GY, Zhi-De D, Croarkin PE. Modelling of transcranial magnetic stimulation (TMS) induced fields in different age groups IFMBE Proceedings. 2021; 81:68-75
  100. Balzekas I, Sladky V, Nejedly P, Brinkmann BH, Crepeau D, Mivalt F, Gregg NM, Pal Attia T, Marks VS, Wheeler L, Riccelli TE, Staab JP, Lundstrom BN, Miller KJ, Van Gompel J, Kremen V, Croarkin PE, Worrell GA. Invasive Electrophysiology for Circuit Discovery and Study of Comorbid Psychiatric Disorders in Patients With Epilepsy: Challenges, Opportunities, and Novel Technologies. Front Hum Neurosci. 2021; 15:702605 Epub 2021 July 26
    View PubMed
  101. Sonmez AI, Lewis CP, Athreya AP, Shekunov J, Croarkin PE. Preliminary Evidence for Anhedonia as a Marker of Sexual Trauma in Female Adolescents. Adolesc Health Med Ther. 2021; 12:67-75 Epub 2021 June 14
    View PubMed
  102. Fatih P, Kucuker MU, Vande Voort JL, Doruk Camsari D, Farzan F, Croarkin PE. A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders. Front Psychiatry. 2021; 12:678088 Epub 2021 June 02
    View PubMed
  103. Kucuker MU, Almorsy AG, Sonmez AI, Ligezka AN, Doruk Camsari D, Lewis CP, Croarkin PE. A Systematic Review of Neuromodulation Treatment Effects on Suicidality. Front Hum Neurosci. 2021; 15:660926 Epub 2021 June 25
    View PubMed
  104. Sonmez AI, Lewis CP, Port JD, Cabello-Arreola A, Blacker CJ, Seewoo BJ, McKean AJ, Leffler JM, Frye MA, Croarkin PE. Glutamatergic Correlates of Bipolar Symptoms in Adolescents. J Child Adolesc Psychopharmacol. 2020 Dec; 30 (10):599-605 Epub 2020 Nov 11
    View PubMed
  105. Nagamitsu S, Mimaki M, Koyanagi K, Tokita N, Kobayashi Y, Hattori R, Ishii R, Matsuoka M, Yamashita Y, Yamagata Z, Igarashi T, Croarkin PE. Prevalence and associated factors of suicidality in Japanese adolescents: results from a population-based questionnaire survey. BMC Pediatr. 2020 Oct 6; 20 (1):467 Epub 2020 Oct 06
    View PubMed
  106. Suresh V, Mills JA, Croarkin PE, Strawn JR. What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression. Depress Anxiety. 2020 Sep; 37 (9):926-934 Epub 2020 June 24
    View PubMed
  107. Sonmez AI, Almorsy A, Ramsey LB, Strawn JR, Croarkin PE. Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations. Depress Anxiety. 2020 Aug; 37 (8):747-759 Epub 2020 May 17
    View PubMed
  108. Seewoo BJ, Hennessy LA, Feindel KW, Etherington SJ, Croarkin PE, Rodger J. Validation of Chronic Restraint Stress Model in Young Adult Rats for the Study of Depression Using Longitudinal Multimodal MR Imaging. eNeuro. 2020 Jul/Aug; 7 (4) Epub 2020 July 30
    View PubMed
  109. Dhami P, Atluri S, Lee JC, Knyahnytska Y, Croarkin PE, Blumberger DM, Daskalakis ZJ, Farzan F. Prefrontal Cortical Reactivity and Connectivity Markers Distinguish Youth Depression from Healthy Youth. Cereb Cortex. 2020 Jun 1; 30 (7):3884-3894
    View PubMed
  110. Ameis SH, Blumberger DM, Croarkin PE, Mabbott DJ, Lai MC, Desarkar P, Szatmari P, Daskalakis ZJ. Treatment of Executive Function Deficits in autism spectrum disorder with repetitive transcranial magnetic stimulation: A double-blind, sham-controlled, pilot trial. Brain Stimul. 2020 May - Jun; 13 (3):539-547 Epub 2020 Jan 15
    View PubMed
  111. Strawn JR, Aaronson ST, Elmaadawi AZ, Schrodt GR, Holbert RC, Verdoliva S, Heart K, Demitrack MA, Croarkin PE. Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance. J Child Adolesc Psychopharmacol. 2020 May; 30 (4):261-266 Epub 2020 Apr 21
    View PubMed
  112. Lewis CP, Port JD, Blacker CJ, Sonmez AI, Seewoo BJ, Leffler JM, Frye MA, Croarkin PE. Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation. Transl Psychiatry. 2020 Apr 23; 10 (1):119
    View PubMed
  113. Sonmez AI, Kucuker MU, Kolla BP, Lewis CP, Kolla BP, Doruk Camsari D, Vande Voort JL, Schak KM, Kung S, Croarkin PE. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 8; 97:109763 Epub 2019 Oct 18
    View PubMed
  114. Bieber ED, Vande Voort JL, Croarkin PE, VON Drehle CT, Simon SM, Hopp BN, Heil HM, Romanowicz M. Documentation Practices for Transgender Youth Admitted to an Inpatient Psychiatric Unit. J Psychiatr Pract. 2020 Mar; 26 (2):153-159
    View PubMed
  115. Strawn JR, Croarkin PE. Commentary: Treatment failure and success: a commentary on defining and treating pediatric treatment-resistant depression - reflections on Dwyer et al. (2020). J Child Psychol Psychiatry 2020 Mar; 61 (3):333-335 Epub 2020 Feb 07
    View PubMed
  116. Nunez NA, Singh B, Romo-Nava F, Joseph B, Veldic M, Cuellar-Barboza A, Cabello Arreola A, Vande Voort JL, Croarkin P, Moore KM, Biernacka J, McElroy SL, Frye MA. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials. Bipolar Disord. 2020 Mar; 22 (2):109-120 Epub 2020 Jan 07
    View PubMed
  117. Shekunov J, Blacker CJ, Vande Voort JL, Tillema JM, Croarkin PE, Romanowicz M. Immune mediated pediatric encephalitis - need for comprehensive evaluation and consensus guidelines. BMC Neurol. 2020 Feb 3; 20 (1):44 Epub 2020 Feb 03
    View PubMed
  118. Hawco C, Yoganathan L, Voineskos AN, Lyon R, Tan T, Daskalakis ZJ, Blumberger DM, Croarkin PE, Lai MC, Szatmari P, Ameis SH. Greater Individual Variability in Functional Brain Activity during Working Memory Performance in young people with Autism and Executive Function Impairment. Neuroimage Clin. 2020; 27:102260 Epub 2020 Apr 23
    View PubMed
  119. Gardea-Resendez M, Kucuker MU, Blacker CJ, Ho AM, Croarkin PE, Frye MA, Veldic M. Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review. Front Pharmacol. 2020; 11:467 Epub 2020 Apr 22
    View PubMed
  120. Shafi RMA, Nakonezny PA, Romanowicz M, Nandakumar AL, Suarez L, Croarkin PE. The Differential Impact of Social Media Use on Middle and High School Students: A Retrospective Study. J Child Adolesc Psychopharmacol. 2019 Dec; 29 (10):746-752 Epub 2019 June 24
    View PubMed
  121. Dhami P, Knyahnytska Y, Atluri S, Lee J, Courtney DB, Croarkin PE, Blumberger DM, Daskalakis ZJ, Farzan F. Feasibility and clinical effects of theta burst stimulation in youth with major depressive disorders: An open-label trial. J Affect Disord. 2019 Nov 1; 258:66-73 Epub 2019 July 30
    View PubMed
  122. Masuda F, Nakajima S, Miyazaki T, Tarumi R, Ogyu K, Wada M, Tsugawa S, Croarkin PE, Mimura M, Noda Y. Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review. Autism. 2019 Oct; 23 (7):1614-1629 Epub 2019 Jan 20
    View PubMed
  123. Betcher HK, Vande Voort JL, Croarkin PE, Gandhi KD, Shekunov J, Larrabee BR, Limbeck MG, Rummans TA, Romanowicz M. Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls. Prim Care Companion CNS Disord. 2019 Aug 15; 21 (4)
    View PubMed
  124. Doruk Camsari D, Lewis CP, Sonmez AI, Nandakumar AL, Gresbrink MA, Daskalakis ZJ, Croarkin PE. Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder. Int J Neuropsychopharmacol. 2019 Jul 1; 22 (7):435-444
    View PubMed
  125. Cheng KS , Croarkin PE , Lee PF . Heart Rate Variability of Various Video-Aided Mindful Deep Breathing Durations and Its Impact on Depression, Anxiety, and Stress Symptom Severity Mindfulness. 05/17/2019; 1-13.
  126. Strawn JR, Mills JA, Croarkin PE. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy. J Child Adolesc Psychopharmacol. 2019 May; 29 (4):250-255 Epub 2019 Feb 27
    View PubMed
  127. Masuda F, Nakajima S, Miyazaki T, Yoshida K, Tsugawa S, Wada M, Ogyu K, Croarkin PE, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y. Motor cortex excitability and inhibitory imbalance in autism spectrum disorder assessed with transcranial magnetic stimulation: a systematic review. Transl Psychiatry. 2019 Mar 7; 9 (1):110 Epub 2019 Mar 07
    View PubMed
  128. Sonmez AI, Camsari DD, Nandakumar AL, Voort JLV, Kung S, Lewis CP, Croarkin PE. Accelerated TMS for Depression: A systematic review and meta-analysis. Psychiatry Res. 2019 Mar; 273:770-781 Epub 2018 Dec 07
    View PubMed
  129. Lewis CP, Camsari DD, Sonmez AI, Nandakumar AL, Gresbrink MA, Daskalakis ZJ, Croarkin PE. Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression. J Affect Disord. 2019 Feb 1; 244:21-24 Epub 2018 Sept 28
    View PubMed
  130. Nandakumar AL, Vande Voort JL, Nakonezny PA, Orth SS, Romanowicz M, Sonmez AI, Ward JA, Rackley SJ, Huxsahl JE, Croarkin PE. Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents. J Child Adolesc Psychopharmacol. 2019 Feb; 29 (1):34-40 Epub 2018 Nov 02
    View PubMed
  131. Croarkin PE, MacMaster FP. Transcranial Magnetic Stimulation for Adolescent Depression. Child Adolesc Psychiatr Clin N Am. 2019 Jan; 28 (1):33-43 Epub 2018 Aug 31
    View PubMed
  132. Veldic M, Ahmed AT, Blacker CJ, Geske JR, Biernacka JM, Borreggine KL, Moore KM, Prieto ML, Vande Voort JL, Croarkin PE, Hoberg AA, Kung S, Alarcon RD, Keeth N, Singh B, Bobo WV, Frye MA. Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications. Front Pharmacol. 2019; 10:83 Epub 2019 Feb 19
    View PubMed
  133. Romanowicz M, Vande Voort JL, Shekunov J, Oesterle TS, Thusius NJ, Rummans TA, Croarkin PE, Karpyak VM, Lynch BA, Schak KM. The effects of parental opioid use on the parent-child relationship and children's developmental and behavioral outcomes: a systematic review of published reports. Child Adolesc Psychiatry Ment Health. 2019; 13:5 Epub 2019 Jan 12
    View PubMed
  134. MacMaster FP, Croarkin PE, Wilkes TC, McLellan Q, Langevin LM, Jaworska N, Swansburg RM, Jasaui Y, Zewdie E, Ciechanski P, Kirton A. Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression. Front Psychiatry. 2019; 10:170 Epub 2019 Mar 29
    View PubMed
  135. Jo HJ, Kenney-Jung DL, Balzekas I, Welker KM, Jones DT, Croarkin PE, Benarroch EE, Worrell GA. Relationship Between Seizure Frequency and Functional Abnormalities in Limbic Network of Medial Temporal Lobe Epilepsy. Front Neurol. 2019; 10:488 Epub 2019 May 08
    View PubMed
  136. Shafi RMA, Bieber ED, Shekunov J, Croarkin PE, Romanowicz M. Evidence Based Dyadic Therapies for 0- to 5-Year-Old Children With Emotional and Behavioral Difficulties. Front Psychiatry. 2019; 10:677 Epub 2019 Sept 18
    View PubMed
  137. Croarkin PE. Indexing the neurobiology of psychotic depression with resting state connectivity: Insights from the STOP-PD study. EBioMedicine 2018 Nov; 37:32-33 Epub 2018 Oct 09
    View PubMed
  138. Markota M, McKean AJ, Romanowicz M, Schak KM, Croarkin PE, Vande Voort JL. Rehospitalization to a child and adolescent psychiatry unit: Role of trauma and bullying. Gen Hosp Psychiatry. 2018 Nov - Dec; 55:10-14 Epub 2018 Aug 30
    View PubMed
  139. Croarkin PE, Nakonezny PA, Deng ZD, Romanowicz M, Voort JLV, Camsari DD, Schak KM, Port JD, Lewis CP. High-frequency repetitive TMS for suicidal ideation in adolescents with depression. J Affect Disord. 2018 Oct 15; 239:282-290 Epub 2018 July 18
    View PubMed
  140. Balzekas I, Lewis CP, Shekunov J, Port JD, Worrell GA, Joon Jo H, Croarkin PE. A pilot study of GABAB correlates with resting-state functional connectivity in five depressed female adolescents. Psychiatry Res Neuroimaging. 2018 Sep 30; 279:60-63 Epub 2018 May 31
    View PubMed
  141. Doruk Camsari D, Kirkovski M, Croarkin PE. Therapeutic Applications of Noninvasive Neuromodulation in Children and Adolescents. Psychiatr Clin North Am. 2018 Sep; 41 (3):465-477
    View PubMed
  142. Doruk Camsari D, Kirkovski M, Croarkin PE. Therapeutic Applications of Invasive Neuromodulation in Children and Adolescents. Psychiatr Clin North Am. 2018 Sep; 41 (3):479-483 Epub 2018 July 17
    View PubMed
  143. Lewis CP, Nakonezny PA, Blacker CJ, Vande Voort JL, Port JD, Worrell GA, Jo HJ, Daskalakis ZJ, Croarkin PE. Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents. Neuropsychopharmacology. 2018 Aug; 43 (9):1822-1831 Epub 2018 Mar 14
    View PubMed
  144. Ginsburg AD, Stadem PS, Takala CR, Croarkin PE, Mattson AB, Billings ML, Brennan RM, Huxsahl JE. An Examination of Screening Tools for Collaborative Care of Adolescent Depression. J Clin Psychiatry. 2018 Jul 17; 79 (4) Epub 2018 July 17
    View PubMed
  145. Heath A, Lindberg DR, Makowiecki K, Gray A, Asp AJ, Rodger J, Choi DS, Croarkin PE. Medium- and high-intensity rTMS reduces psychomotor agitation with distinct neurobiologic mechanisms. Transl Psychiatry. 2018 Jul 5; 8 (1):126 Epub 2018 July 05
    View PubMed
  146. Abujadi C, Croarkin PE, Bellini BB, Brentani H, Marcolin MA. Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study. Braz J Psychiatry. 2018 Jul-Sep; 40 (3):309-311 Epub 2017 Dec 11
    View PubMed
  147. Strawn JR, Croarkin PE. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research. J Child Adolesc Psychopharmacol 2018 Jun; 28 (5):363 Epub 2018 Apr 05
    View PubMed
  148. Storlie CB, Myers SM, Katusic SK, Weaver AL, Voigt RG, Croarkin PE, Stoeckel RE, Port JD. Clustering and variable selection in the presence of mixed variable types and missing data. Stat Med. 2018 May 17 [Epub ahead of print]
    View PubMed
  149. Na PJ, Yaramala SR, Kim JA, Kim H, Goes FS, Zandi PP, Vande Voort JL, Sutor B, Croarkin P, Bobo WV. The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)-9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS). J Affect Disord. 2018 May; 232:34-40 Epub 2018 Feb 17
    View PubMed
  150. Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials. J Child Adolesc Psychopharmacol. 2018 Feb; 28 (1):2-9 Epub 2017 Aug 28
    View PubMed
  151. Shafi RMA, Vande Voort JL, Croarkin PE, Romanowicz M. Parent-Child Interaction Therapy in a Case of Global Developmental Delay and Leukoencephalopathy. Front Psychiatry. 2018; 9:427 Epub 2018 Sept 10
    View PubMed
  152. Lee PF, Kan DPX, Croarkin P, Phang CK, Doruk D. Neurophysiological correlates of depressive symptoms in young adults: A quantitative EEG study. J Clin Neurosci. 2018 Jan; 47:315-322 Epub 2017 Oct 21
    View PubMed
  153. Croarkin PE, Luby JL, Cercy K, Geske JR, Veldic M, Simonson M, Joshi PT, Wagner KD, Walkup JT, Nassan MM, Cuellar-Barboza AB, Casuto L, McElroy SL, Jensen PS, Frye MA, Biernacka JM. Genetic Risk Score Analysis in Early-Onset Bipolar Disorder. J Clin Psychiatry. 2017 Nov-Dec; 78 (9):1337-1343
    View PubMed
  154. Ameis SH, Daskalakis ZJ, Blumberger DM, Desarkar P, Drmic I, Mabbott DJ, Lai MC, Croarkin PE, Szatmari P. Repetitive Transcranial Magnetic Stimulation for the Treatment of Executive Function Deficits in Autism Spectrum Disorder: Clinical Trial Approach. J Child Adolesc Psychopharmacol. 2017 Jun; 27 (5):413-421 Epub 2017 Mar 27
    View PubMed
  155. Zarate-Garza PP, Biggs BK, Croarkin P, Morath B, Leffler J, Cuellar-Barboza A, Tye SJ. How Well Do We Understand the Long-Term Health Implications of Childhood Bullying? Harv Rev Psychiatry. 2017 Mar/Apr; 25 (2):89-95
    View PubMed
  156. Nassan M, Li Q, Croarkin PE, Chen W, Colby CL, Veldic M, McElroy SL, Jenkins GD, Ryu E, Cunningham JM, Leboyer M, Frye MA, Biernacka JM. A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model. J Affect Disord. 2017 Jan 15; 208:120-129. Epub 2016 Sep 30.
    View PubMed
  157. Lee JC, Lewis CP, Daskalakis ZJ, Croarkin PE. Transcranial Direct Current Stimulation: Considerations for Research in Adolescent Depression. Front Psychiatry. 2017; 8:91 Epub 2017 June 07
    View PubMed
  158. Lee JC, Croarkin PE, Ameis SH, Sun Y, Blumberger DM, Rajji TK, Daskalakis ZJ. Paired-Associative Stimulation-Induced Long-term Potentiation-Like Motor Cortex Plasticity in Healthy Adolescents. Front Psychiatry. 2017; 8:95 Epub 2017 May 29
    View PubMed
  159. Kan DPX, Croarkin PE, Phang CK, Lee PF. EEG differences between eyes-closed and eyes-open conditions at the resting stage for euthymic participants Neurophysiology. 2017; 49 (6):432-40
  160. Ameis SH, Lerch JP, Taylor MJ, Lee W, Viviano JD, Pipitone J, Nazeri A, Croarkin PE, Voineskos AN, Lai MC, Crosbie J, Brian J, Soreni N, Schachar R, Szatmari P, Arnold PD, Anagnostou E. A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior Relationships. Am J Psychiatry. 2016 Dec 01; 173: (12)1213-1222.
    View PubMed
  161. Croarkin PE, Rotenberg A. Pediatric Neuromodulation Comes of Age. J Child Adolesc Psychopharmacol. 2016 Sep; 26 (7):578-81 Epub 2016 Sept 07
    View PubMed
  162. Wall CA, Croarkin PE, Maroney-Smith MJ, Haugen LM, Baruth JM, Frye MA, Sampson SM, Port JD. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder. J Child Adolesc Psychopharmacol. 2016 Sep; 26 (7):582-9 Epub 2016 Feb 05
    View PubMed
  163. Cullen KR, Jasberg S, Nelson B, Klimes-Dougan B, Lim KO, Croarkin PE. Seizure Induced by Deep Transcranial Magnetic Stimulation in an Adolescent with Depression. J Child Adolesc Psychopharmacol. 2016 Sep; 26 (7):637-41 Epub 2016 July 22
    View PubMed
  164. Bobo WV, Vande Voort JL, Croarkin PE, Leung JG, Tye SJ, Frye MA. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. Depress Anxiety. 2016 Aug; 33 (8):698-710 Epub 2016 Apr 06
    View PubMed
  165. Mason BL, Brown ES, Croarkin PE. Historical Underpinnings of Bipolar Disorder Diagnostic Criteria. Behav Sci (Basel). 2016 Jul 15; 6 (3) Epub 2016 July 15
    View PubMed
  166. Scola G, McNamara RK, Croarkin PE, Leffler JM, Cullen KR, Geske JR, Biernacka JM, Frye MA, DelBello MP, Andreazza AC. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. J Affect Disord. 2016 Mar 1; 192:176-83 Epub 2015 Dec 23
    View PubMed
  167. Melton TH, Croarkin PE, Strawn JR, McClintock SM. Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis. J Psychiatr Pract. 2016 Mar; 22 (2):84-98
    View PubMed
  168. Croarkin PE, Nakonezny PA, Wall CA, Murphy LL, Sampson SM, Frye MA, Port JD. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents. Psychiatry Res Neuroimaging. 2016 Jan 30; 247:25-33 Epub 2015 Nov 27
    View PubMed
  169. Lewis CP, Nakonezny PA, Ameis SH, Vande Voort JL, Husain MM, Emslie GJ, Daskalakis ZJ, Croarkin PE. Cortical inhibitory and excitatory correlates of depression severity in children and adolescents. J Affect Disord. 2016 Jan 15; 190:566-575 Epub 2015 Oct 28
    View PubMed
  170. Nagamitsu S, Sakurai R, Matsuoka M, Chiba H, Ozono S, Tanigawa H, Yamashita Y, Kaida H, Ishibashi M, Kakuma T, Croarkin PE, Matsuishi T. Altered SPECT (123)I-iomazenil Binding in the Cingulate Cortex of Children with Anorexia Nervosa. Front Psychiatry. 2016; 7:16 Epub 2016 Feb 16
    View PubMed
  171. Croarkin PE, Ameis SH. Editorial: Frontiers in Brain-Based Therapeutic Interventions and Biomarker Research in Child and Adolescent Psychiatry. Front Psychiatry. 2016; 7:123 Epub 2016 July 05
    View PubMed
  172. Lewis CP, Port JD, Frye MA, Vande Voort JL, Ameis SH, Husain MM, Daskalakis ZJ, Croarkin PE. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents. Front Neural Circuits. 2016; 10:98 Epub 2016 Nov 29
    View PubMed
  173. Nassan M, Croarkin PE, Luby JL, Veldic M, Joshi PT, McElroy SL, Post RM, Walkup JT, Cercy K, Geske JR, Wagner KD, Cuellar-Barboza AB, Casuto L, Lavebratt C, Schalling M, Jensen PS, Biernacka JM, Frye MA. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disord. 2015 Sep; 17 (6):645-52
    View PubMed
  174. Croarkin PE, Thomas MA, Port JD, Baruth JM, Choi DS, Abulseoud OA, Frye MA. N-acetylaspartate normalization in bipolar depression after lamotrigine treatment. Bipolar Disord. 2015 Jun; 17 (4):450-7 Epub 2014 Dec 12
    View PubMed
  175. Wehry AM, McNamara RK, Adler CM, Eliassen JC, Croarkin P, Cerullo MA, DelBello MP, Strawn JR. Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: a voxel-based morphometry study. J Affect Disord. 2015 Jan 15; 171:54-9 Epub 2014 Sept 16
    View PubMed
  176. Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015; 11:1193-212 Epub 2015 Aug 12
    View PubMed
  177. Nagamitsu S, Yamashita Y, Tanigawa H, Chiba H, Kaida H, Ishibashi M, Kakuma T, Croarkin PE, Matsuishi T. Upregulated GABA Inhibitory Function in ADHD Children with Child Behavior Checklist-Dysregulation Profile: 123I-Iomazenil SPECT Study. Front Psychiatry. 2015; 6:84 Epub 2015 June 02
    View PubMed
  178. Cockerill RG, Biggs BK, Oesterle TS, Croarkin PE. Antidepressant use and body mass index change in overweight adolescents: a historical cohort study. Innov Clin Neurosci. 2014 Nov-Dec; 11 (11-12):14-21
    View PubMed
  179. Bobo WV, Pathak J, Kremers HM, Yawn BP, Brue SM, Stoppel CJ, Croarkin PE, St Sauver J, Frye MA, Rocca WA. An electronic health record driven algorithm to identify incident antidepressant medication users. J Am Med Inform Assoc. 2014 Sep-Oct; 21 (5):785-91 Epub 2014 Apr 29
    View PubMed
  180. Croarkin PE, Nakonezny PA, Husain MM, Port JD, Melton T, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ. Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine. Brain Stimul. 2014 Mar-Apr; 7 (2):243-51 Epub 2013 Dec 03
    View PubMed
  181. Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM. Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report. Neuropsychiatr Dis Treat. 2014; 10:2049-55 Epub 2014 Oct 31
    View PubMed
  182. Croarkin PE, Nakonezny PA, Lewis CP, Zaccariello MJ, Huxsahl JE, Husain MM, Kennard BD, Emslie GJ, Daskalakis ZJ. Developmental aspects of cortical excitability and inhibition in depressed and healthy youth: an exploratory study. Front Hum Neurosci. 2014; 8:669 Epub 2014 Sept 02
    View PubMed
  183. Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry. 2013 Mar; 70 (3):291-9
    View PubMed
  184. Wall CA, Croarkin PE, McClintock SM, Murphy LL, Bandel LA, Sim LA, Sampson SM. Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder. Front Psychiatry. 2013; 4:165 Epub 2013 Dec 12
    View PubMed
  185. Tian F, Kozel FA, Yennu A, Croarkin PE, McClintock SM, Mapes KS, Husain MM, Liu H. Test-retest assessment of cortical activation induced by repetitive transcranial magnetic stimulation with brain atlas-guided optical topography. J Biomed Opt. 2012 Nov; 17(11):116020.
    View PubMed
  186. Wall CA, Croarkin PE, Swintak C, Koplin BA. Psychiatric pharmacogenomics in pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am. 2012 Oct; 21(4):773-88.
    View PubMed
  187. Croarkin PE, Wall CA, Nakonezny PA, Buyukdura JS, Husain MM, Sampson SM, Emslie GJ, Kozel FA. Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorder. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):56-64. Epub 2012 Jan 18.
    View PubMed
  188. Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Zhu L, Tao R, Hughes C, Croarkin P. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):21-8. Epub 2012 Jan 18.
    View PubMed
  189. Croarkin PE, Wall CA, Lee J. Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry. Int Rev Psychiatry. 2011 Oct; 23(5):445-53.
    View PubMed
  190. Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SM. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011 Sep; 72 (9):1263-9
    View PubMed
  191. Buyukdura JS, McClintock SM, Croarkin PE. Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):395-409. Epub 2010 Oct 31.
    View PubMed
  192. Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH. Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Front Psychiatry. 2011; 2:7. Epub 2011 Mar 08.
    View PubMed
  193. Croarkin PE, Levinson AJ, Daskalakis ZJ. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev. 2011 Jan; 35(3):818-25. Epub 2010 Oct 12.
    View PubMed
  194. Croarkin PE, Wall CA, McClintock SM, Kozel FA, Husain MM, Sampson SM. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT. 2010 Dec; 26(4):323-9.
    View PubMed
  195. Elmquist JM, Melton TK, Croarkin P, McClintock SM. A systematic overview of measurement-based care in the treatment of childhood and adolescent depression. J Psychiatr Pract. 2010 Jul; 16(4):217-34.
    View PubMed
  196. Khan AA, Strawn JR, Croarkin PE. Emerging Treatment Options in Bipolar Disorder in Adolescents: Focus on Ziprasidone. Adolescent Health Medicine and Therapeutics. 2010; 1:137-143.
  197. Kozel FA, Tian F, Dhamne S, Croarkin PE, McClintock SM, Elliott A, Mapes KS, Husain MM, Liu H. Using simultaneous repetitive Transcranial Magnetic Stimulation/functional Near Infrared Spectroscopy (rTMS/fNIRS) to measure brain activation and connectivity. Neuroimage. 2009 Oct 1; 47(4):1177-84. Epub 2009 May 14.
    View PubMed
  198. Croarkin PE, McCaffrey PC, McClintock SM, Rodez C, Husain MM. Electroconvulsive Therapy in Child and Adolescent Psychiatry. Current Psychiatry Reviews 5(4). 2009:298-305.
  199. Croarkin PE, Emslie GJ, Mayes TL. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry. 2008 Jul; 69(7):1157-65.
    View PubMed
  200. Yanofski J, Croarkin P. Choosing Antidepressants for HIV and AIDS Patients: Insights on Safety and Side Effects. Psychiatry (Edgmont). 2008 May; 5(5):61-6.
    View PubMed
  201. Croarkin P, Berg J, Spira J. Informed consent for psychotherapy: a look at therapists' understanding, opinions, and practices. Am J Psychother. 2003; 57(3):384-400.
    View PubMed
  202. Croarkin P. From King George to neuroglobin: the psychiatric aspects of acute intermittent porphyria. J Psychiatr Pract. 2002 Nov; 8(6):398-405.
    View PubMed
PST-20226495